“Neuralink, the company owned by Elon Musk, has been penalized for storing hazardous materials without adhering to proper protocols.”

At a time when Tesla just suffered its biggest daily share price decline since 2020 following a “catastrophic” earnings call, Reuters came out with a report claiming Elon Musk’s brain implant project NeuraLink have flagged hazardous materials The protocol has been stored inappropriately.

That is, according to documents seen by Reuters, the U.S. Department of Transportation (DOT) investigators found hazardous waste, including liquid xylene – which is not only flammable but can also cause “headaches, dizziness, confusion, loss of nerve function” and death,” according to the CDC . In a February 2023 inspection of NeuraLink facilities in Texas and California, the DOT also found improper packaging of hazardous materials

Elon Musk,As a result of this finding, the original penalty was reduced to $2,480 for NeuraLink. The DOT also found that NeuraLink failed to register as a carrier of hazardous materials as required by applicable law.

A spokesman for the Pipeline and Hazardous Materials Safety Administration, an agency under the Department of Transportation, whose inspectors physically visited the Neuralink facilities in February 2023, confirmed to Reuters the nature of the violations and the resulting penalties came to brainstorming start-ups was that speaker added that the investigation is now closed.

The investigation began after Reuters reported complaints from Neuralink about a rapid animal test the startup used to relieve human paralysis in about 1,500 animals, including sheep, pigs and monkeys, using brain a are replaced which took care of the bridge animals that allegedly caused needless suffering and death You have been killed

In September 2023, the U.S. The FDA cleared NeuraLink for initial human trials. The company commented in its press release:

During the study, the R1 Robot will be used to surgically implant the ultra-fine, flexible wires of the N1 Implant into a brain area that controls movement. Once installed, the N1 is aesthetically invisible and is designed to capture and transmit brain signals that indicate movement and thought in the app. The first goal of our BCI [Brain-Computer Interface] is to give people the ability to use only their minds to control a computer cursor or keyboard.

In June 2023, the private equity market will value Neuralink at around $5 billion, surpassing the $2 billion valuation that the startup set for 2021.

The California Department of Occupational Safety and Health (Cal/OSHA) has fined Neuralink, the neurotechnology company founded by Elon Musk, $4,125 for failing to meet safety standards for storing hazardous materials including brain tissue and materials including cracking The information, dated June 8, 2022, and released this week, details several violations discovered during a Cal/OSHA inspection of Neuralink’s Fremont, Calif., facilities in April later Inspectors found that the company used brain tissue samples, explosives used in research, . to clean surgical instruments and does not store or label hazardous materials such as medicines properly

Basically, the quote says that Neuralink failed:

• Properly label hazardous materials containers with important information such as product names, hazards, and necessary safety precautions
• Keep hazardous materials in a designated storage area out of reach of unauthorized personnel.
• Train employees in the proper handling and storage of hazardous materials.

“We are committed to the safety of our employees and have taken all necessary steps to address the issues raised by Cal/OSHA,” the company said. “We believe we have met all the requirements of the citation and are moving forward with continuous safety improvements.”

This is not the first time NeuraLink has been sued for security breaches. In 2021, Cal/OSHA cited the company for not reporting workplace injuries.

NeuraLink is developing a brain-computer interface (BCI) that allows people to control computers and other devices with their imagination. The company has raised more than $2 billion and aims to begin human trials of its BCI in 2023.

READ MORE LATEST NEWS CLICK HERE – www.newsomeprint.com

click here for latest gadgets –https://www.amazon.in/shop/artichaudhary105